HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection

BACKGROUND: Hepatitis B Surface antigen (HBsAg) seroclearance and seroconversion (development of antibodies against HBsAg) can increases the survival of Chronic hepatitis B (CHB) patients. The aim of this study was to determine the percentage and timing of HBsAg seroclearance and seroconversion in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Masrour-Roudsari, Jila, Hasanjani-Roushan, Mohammadreza, Yahyapour, Yousef, Barari-Savadkoohi, Rahim, Bijani, Ali, Sadeghi, Farzin, Mohammadnia-Afroozi, Mousa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265509/
https://www.ncbi.nlm.nih.gov/pubmed/32509250
http://dx.doi.org/10.22088/cjim.11.2.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265509/
https://www.ncbi.nlm.nih.gov/pubmed/32509250
http://dx.doi.org/10.22088/cjim.11.2.205

Ejemplares similares